CARA Therapeutics, Inc.

( )
CARA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.54%75.040.0%$1242.25m
NVAXNovavax, Inc. 5.42%109.97102.0%$942.55m
VXRTVaxart, Inc. 40.02%16.970.0%$747.74m
AMGNAmgen, Inc. 1.22%253.091.3%$694.77m
REGNRegeneron Pharmaceuticals, Inc. 4.12%641.232.5%$656.50m
GILDGilead Sciences, Inc. 0.67%77.191.0%$630.00m
BIIBBiogen, Inc. 1.72%281.271.6%$603.02m
VRTXVertex Pharmaceuticals, Inc. 3.16%293.831.9%$475.24m
ILMNIllumina, Inc. 1.93%376.253.5%$302.26m
BNTXBioNTech SE 7.84%83.880.0%$222.50m
BMRNBioMarin Pharmaceutical, Inc. 1.63%126.434.3%$213.99m
ALXNAlexion Pharmaceuticals, Inc. 1.44%108.571.9%$207.78m
SGENSeattle Genetics, Inc. 2.88%173.436.1%$191.51m
SRNESorrento Therapeutics, Inc. 2.85%7.941.8%$187.49m
IMMUImmunomedics, Inc. 1.70%40.6511.0%$175.52m

Company Profile

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.